Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study
- Ana Verdelho1,
- Sofia Madureira1,
- José M Ferro1,
- Anna-Maria Basile2,
- Hugues Chabriat3,
- Timo Erkinjuntti4,
- Franz Fazekas5,
- Michael Hennerici6,
- John O’Brien7,
- Leonardo Pantoni2,
- Emilia Salvadori2,
- Philip Scheltens8,
- Marieke C Visser8,
- Lars-Olof Wahlund9,
- Gunhild Waldemar10,
- Anders Wallin11,
- Domenico Inzitari2,
- on behalf of the LADIS Study
- 1Neurology Department, Centro de Estudos Egas Moniz, Santa Maria Hospital, Lisbon, Portugal
- 2Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy
- 3Department of Neurology, Hôpital Lariboisière, Paris, France
- 4Memory Research Unit, Department of Clinical Neurosciences, Helsinki University, Helsinki, Finland
- 5Department of Neurology and MRI Institute, Karl Franzens University Graz, Graz, Austria
- 6Department of Neurology, University of Heidelberg, Klinikum Mannheim, Mannheim, Germany
- 7Institute for Ageing and Health, University of Newcastle, Newcastle-upon-Tyne, UK
- 8Department of Neurology, VU Medical Centre, Amsterdam, the Netherlands
- 9Karolinska Institute, Department of Clinical Neuroscience and Family Medicine, Huddinge University Hospital, Huddinge, Sweden
- 10Memory Disorders Research Unit, Department of Neurology, Copenhagen University Hospital, Copenhagen, Denmark
- 11Institute of Clinical Neuroscience, Göteborg University, Göteborg, Sweden
- Dr Ana Verdelho, Department of Neurosciences, Hospital Santa Maria, 1649-035 Lisbon, Portugal; averdelho{at}netcabo.pt
- Received 28 November 2006
- Revised 27 March 2007
- Accepted 31 March 2007
- Published Online First 30 April 2007
Abstract
Background and purpose: Age related white matter changes (ARWMC) are frequent in non-demented old subjects and are associated with impaired cognitive function. Our aim was to study the influence of vascular risk factors and ARWMC on the neuropsychological performance of an independent elderly population, to see if vascular risk factors impair cognition in addition to the effects of ARWMC.
Methods: Independent subjects, aged 65–84 years, with any degree of ARWMC were assessed using a comprehensive neuropsychological battery including the Mini-Mental State Examination (MMSE), VADAS-Cog (Alzheimer’s disease assessment scale) and the Stroop and Trail Making test. Vascular risk factors were recorded and ARWMC (measured by MRI) were graded into three classes. The impact of vascular risk factors and ARWMC on neuropsychological performance was assessed by linear regression analyses, with adjustment for age and education.
Results: 638 patients (74.1 (5) years old, 55% women) were included. Patients with severe ARWMC performed significantly worse on global tests of cognition, executive functions, speed and motor control, attention, naming and visuoconstructional praxis. Diabetes interfered with tests of executive function, attention, speed and motor control, memory and naming. Arterial hypertension and stroke influenced executive functions and attention. The effect of these vascular risk factors was independent of the severity of ARWMC, age and education.
Conclusion: ARWMC is related to worse performance in executive function, attention and speed. Diabetes, hypertension and previous stroke influenced neuropsychological performance, independently of the severity of ARWMC, stressing the need to control vascular risk factors in order to prevent cognitive decline in the elderly.
Footnotes
-
Competing interests: None.
- Abbreviations:
- ADAS
- Alzheimer’s Disease Assessment Scale
- ARWMC
- age related white matter changes
- LADIS study
- Leukoaraiosis and Disability study
- MMSE
- Mini-Mental State Examination
- TM
- Trail Making







